Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Endogenous Calcification Inhibitors in the Prevention of Vascular Calcification: A Consensus Statement From the COST Action EuroSoftCalcNet.

Bäck M, Aranyi T, Cancela ML, Carracedo M, Conceição N, Leftheriotis G, Macrae V, Martin L, Nitschke Y, Pasch A, Quaglino D, Rutsch F, Shanahan C, Sorribas V, Szeri F, Valdivielso P, Vanakker O, Kempf H.

Front Cardiovasc Med. 2019 Jan 18;5:196. doi: 10.3389/fcvm.2018.00196. eCollection 2018. Review.

2.

Endogenous H2S production deficiencies lead to impaired renal erythropoietin production.

Leigh J, Juriasingani S, Akbari M, Shao P, Saha MN, Lobb I, Bachtler M, Fernandez B, Qian Z, Van Goor H, Pasch A, Feelisch M, Wang R, Sener A.

Can Urol Assoc J. 2018 Nov 20. doi: 10.5489/cuaj.5658. [Epub ahead of print]

PMID:
30472982
3.

Control of metabolic predisposition to cardiovascular complications of chronic kidney disease by effervescent calcium magnesium citrate: a feasibility study.

Quiñones H, Hamdi T, Sakhaee K, Pasch A, Moe OW, Pak CYC.

J Nephrol. 2019 Feb;32(1):93-100. doi: 10.1007/s40620-018-0559-2. Epub 2018 Nov 21.

PMID:
30465137
4.

Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial.

Andrews ES, Perrenoud L, Nowak KL, You Z, Pasch A, Chonchol M, Kendrick J, Jalal D.

PLoS One. 2018 Oct 24;13(10):e0205831. doi: 10.1371/journal.pone.0205831. eCollection 2018.

5.

Phosphate, Calcification in Blood, and Mineral Stress: The Physiologic Blood Mineral Buffering System and Its Association with Cardiovascular Risk.

Pasch A, Jahnen-Dechent W, Smith ER.

Int J Nephrol. 2018 Sep 2;2018:9182078. doi: 10.1155/2018/9182078. eCollection 2018. Review.

6.

Effect of Treatment of Metabolic Acidosis on Vascular Endothelial Function in Patients with CKD: A Pilot Randomized Cross-Over Study.

Kendrick J, Shah P, Andrews E, You Z, Nowak K, Pasch A, Chonchol M.

Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1463-1470. doi: 10.2215/CJN.00380118. Epub 2018 Sep 20.

PMID:
30237219
7.

Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score.

Ussif A, Pihlstrøm H, Pasch A, Holdaas H, Hartmann A, Smerud K, Åsberg A.

BMC Nephrol. 2018 Aug 22;19(1):212. doi: 10.1186/s12882-018-1000-8.

8.

The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical Trial.

Bressendorff I, Hansen D, Schou M, Pasch A, Brandi L.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1373-1380. doi: 10.2215/CJN.13921217. Epub 2018 Aug 21.

PMID:
30131425
9.

Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients.

Bostom A, Pasch A, Madsen T, Roberts MB, Franceschini N, Steubl D, Garimella PS, Ix JH, Tuttle KR, Ivanova A, Shireman T, Gohh R, Merhi B, Jarolim P, Kusek JW, Pfeffer MA, Liu S, Eaton CB.

Am J Nephrol. 2018;48(1):21-31. doi: 10.1159/000491025. Epub 2018 Jul 11.

PMID:
29996127
10.

Urinary Excretion of Sulfur Metabolites and Risk of Cardiovascular Events and All-Cause Mortality in the General Population.

van den Born JC, Frenay AS, Koning AM, Bachtler M, Riphagen IJ, Minovíc I, Feelisch M, Dekker MM, Bulthuis MLC, Gansevoort RT, Hillebrands JL, Pasch A, Bakker SJL, van Goor H.

Antioxid Redox Signal. 2018 Jul 25. doi: 10.1089/ars.2017.7040. [Epub ahead of print]

PMID:
29905081
11.

Acetate-free, citrate-acidified bicarbonate dialysis improves serum calcification propensity-a preliminary study.

Lorenz G, Mayer CC, Bachmann Q, Stryeck S, Braunisch MC, Haller B, Carbajo-Lozoya J, Schmidt A, Witthauer S, Abuzahu J, Kemmner S, Angermann S, Koneru N, Wassertheurer S, Bieber R, Heemann U, Madl T, Pasch A, Schmaderer C.

Nephrol Dial Transplant. 2018 Nov 1;33(11):2043-2051. doi: 10.1093/ndt/gfy134.

PMID:
29860419
12.

Serum Uromodulin: A Biomarker of Long-Term Kidney Allograft Failure.

Bostom A, Steubl D, Garimella PS, Franceschini N, Roberts MB, Pasch A, Ix JH, Tuttle KR, Ivanova A, Shireman T, Kim SJ, Gohh R, Weiner DE, Levey AS, Hsu CY, Kusek JW, Eaton CB.

Am J Nephrol. 2018;47(4):275-282. doi: 10.1159/000489095. Epub 2018 Apr 26.

PMID:
29698955
13.

Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB.

Voelkl J, Tuffaha R, Luong TTD, Zickler D, Masyout J, Feger M, Verheyen N, Blaschke F, Kuro-O M, Tomaschitz A, Pilz S, Pasch A, Eckardt KU, Scherberich JE, Lang F, Pieske B, Alesutan I.

J Am Soc Nephrol. 2018 Jun;29(6):1636-1648. doi: 10.1681/ASN.2017050492. Epub 2018 Apr 13.

PMID:
29654213
14.

Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus.

Dahdal S, Devetzis V, Chalikias G, Tziakas D, Chizzolini C, Ribi C, Trendelenburg M, Eisenberger U, Hauser T, Pasch A, Huynh-Do U, Arampatzis S; Swiss Systemic Lupus Erythematosus Cohort Study Group.

PLoS One. 2018 Jan 24;13(1):e0188695. doi: 10.1371/journal.pone.0188695. eCollection 2018.

15.

Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity-A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial.

Bressendorff I, Hansen D, Schou M, Silver B, Pasch A, Bouchelouche P, Pedersen L, Rasmussen LM, Brandi L.

Kidney Int Rep. 2016 Dec 30;2(3):380-389. doi: 10.1016/j.ekir.2016.12.008. eCollection 2017 May.

16.

Worsening calcification propensity precedes all-cause and cardiovascular mortality in haemodialyzed patients.

Lorenz G, Steubl D, Kemmner S, Pasch A, Koch-Sembdner W, Pham D, Haller B, Bachmann Q, Mayer CC, Wassertheurer S, Angermann S, Lech M, Moog P, Bauer A, Heemann U, Schmaderer C.

Sci Rep. 2017 Oct 17;7(1):13368. doi: 10.1038/s41598-017-12859-6.

17.

A rapid and sustained improvement of calcification propensity score (serum T50 ) after successful kidney transplantation: Reanalysis of a randomized controlled trial of ibandronate.

Smerud KT, Åsberg A, Kile H, Pasch A, Dahle DO, Bollerslev J, Godang K, Hartmann A.

Clin Transplant. 2017 Dec;31(12). doi: 10.1111/ctr.13131. Epub 2017 Oct 26.

PMID:
28972673
18.

Hydrogen sulfide attenuates calcification of vascular smooth muscle cells via KEAP1/NRF2/NQO1 activation.

Aghagolzadeh P, Radpour R, Bachtler M, van Goor H, Smith ER, Lister A, Odermatt A, Feelisch M, Pasch A.

Atherosclerosis. 2017 Oct;265:78-86. doi: 10.1016/j.atherosclerosis.2017.08.012. Epub 2017 Aug 19.

PMID:
28865326
19.

Hope for CKD-MBD Patients: New Diagnostic Approaches for Better Treatment of CKD-MBD.

Hocher B, Pasch A.

Kidney Dis (Basel). 2017 Jul;3(1):8-14. doi: 10.1159/000477244. Epub 2017 Jun 16. Review.

20.

A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum.

Smith ER, Hewitson TD, Cai MMX, Aghagolzadeh P, Bachtler M, Pasch A, Holt SG.

Sci Rep. 2017 Jul 18;7(1):5686. doi: 10.1038/s41598-017-05474-y.

21.

Serum calcification propensity is associated with renal tissue oxygenation and resistive index in patients with arterial hypertension or chronic kidney disease.

Pruijm M, Lu Y, Megdiche F, Piskunowicz M, Milani B, Stuber M, Bachtler M, Vogt B, Burnier M, Pasch A.

J Hypertens. 2017 Oct;35(10):2044-2052. doi: 10.1097/HJH.0000000000001406.

PMID:
28562422
22.

The Reactive Species Interactome: Evolutionary Emergence, Biological Significance, and Opportunities for Redox Metabolomics and Personalized Medicine.

Cortese-Krott MM, Koning A, Kuhnle GGC, Nagy P, Bianco CL, Pasch A, Wink DA, Fukuto JM, Jackson AA, van Goor H, Olson KR, Feelisch M.

Antioxid Redox Signal. 2017 Oct 1;27(10):684-712. doi: 10.1089/ars.2017.7083. Epub 2017 Jun 6. Review.

23.

Phosphocalcic Markers and Calcification Propensity for Assessment of Interstitial Fibrosis and Vascular Lesions in Kidney Allograft Recipients.

Berchtold L, Ponte B, Moll S, Hadaya K, Seyde O, Bachtler M, Vallée JP, Martin PY, Pasch A, de Seigneux S.

PLoS One. 2016 Dec 30;11(12):e0167929. doi: 10.1371/journal.pone.0167929. eCollection 2016.

24.

Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.

Pasch A, Block GA, Bachtler M, Smith ER, Jahnen-Dechent W, Arampatzis S, Chertow GM, Parfrey P, Ma X, Floege J.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):315-322. doi: 10.2215/CJN.04720416. Epub 2016 Dec 9.

25.

The fate of sulfate in chronic heart failure.

Koning AM, Meijers WC, Minović I, Post A, Feelisch M, Pasch A, Leuvenink HG, de Boer RA, Bakker SJ, van Goor H.

Am J Physiol Heart Circ Physiol. 2017 Mar 1;312(3):H415-H421. doi: 10.1152/ajpheart.00645.2016. Epub 2016 Dec 6.

26.

Serum free sulfhydryl status is associated with patient and graft survival in renal transplant recipients.

Frenay AS, de Borst MH, Bachtler M, Tschopp N, Keyzer CA, van den Berg E, Bakker SJL, Feelisch M, Pasch A, van Goor H.

Free Radic Biol Med. 2016 Oct;99:345-351. doi: 10.1016/j.freeradbiomed.2016.08.024. Epub 2016 Aug 20.

PMID:
27554970
27.

Serum free thiols in chronic heart failure.

Koning AM, Meijers WC, Pasch A, Leuvenink HGD, Frenay AS, Dekker MM, Feelisch M, de Boer RA, van Goor H.

Pharmacol Res. 2016 Sep;111:452-458. doi: 10.1016/j.phrs.2016.06.027. Epub 2016 Jul 1.

PMID:
27378569
28.

Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α.

Aghagolzadeh P, Bachtler M, Bijarnia R, Jackson C, Smith ER, Odermatt A, Radpour R, Pasch A.

Atherosclerosis. 2016 Aug;251:404-414. doi: 10.1016/j.atherosclerosis.2016.05.044. Epub 2016 May 27.

PMID:
27289275
29.

Novel assessments of systemic calcification propensity.

Pasch A.

Curr Opin Nephrol Hypertens. 2016 Jul;25(4):278-84. doi: 10.1097/MNH.0000000000000237. Review.

PMID:
27228365
30.

When extracorporeal CPR fails-fatal ionized hypocalcemia during cardiac arrest.

Horn P, Pasch A, Maxhera B, Kelm M, Westenfeld R.

Am J Emerg Med. 2016 Nov;34(11):2251.e1-2251.e2. doi: 10.1016/j.ajem.2016.03.060. Epub 2016 Apr 1. No abstract available.

PMID:
27113129
31.

High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity.

Dekker M, Pasch A, van der Sande F, Konings C, Bachtler M, Dionisi M, Meier M, Kooman J, Canaud B.

PLoS One. 2016 Apr 11;11(4):e0151508. doi: 10.1371/journal.pone.0151508. eCollection 2016. Erratum in: PLoS One. 2016;11(6):e0156923.

32.

High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.

van den Born JC, Frenay AR, Bakker SJ, Pasch A, Hillebrands JL, Lambers Heerspink HJ, van Goor H.

Nitric Oxide. 2016 May 1;55-56:18-24. doi: 10.1016/j.niox.2016.03.001. Epub 2016 Mar 4.

PMID:
26952289
33.

High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification.

Barbieri S, Schroeder C, Froehlich JM, Pasch A, Thoeny HC.

Contrast Media Mol Imaging. 2016 May;11(3):245-50. doi: 10.1002/cmmi.1683. Epub 2016 Jan 11.

34.

Environmental impact assessment of wood ash utilization in forest road construction and maintenance--A field study.

Oburger E, Jäger A, Pasch A, Dellantonio A, Stampfer K, Wenzel WW.

Sci Total Environ. 2016 Feb 15;544:711-21. doi: 10.1016/j.scitotenv.2015.11.123. Epub 2015 Dec 10.

PMID:
26674700
35.

Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial.

Bristow SM, Gamble GD, Pasch A, O'Neill WC, Stewart A, Horne AM, Reid IR.

Osteoporos Int. 2016 Mar;27(3):1209-1216. doi: 10.1007/s00198-015-3372-y. Epub 2015 Oct 22.

PMID:
26493812
36.

The Vacuolar H+-ATPase B1 Subunit Polymorphism p.E161K Associates with Impaired Urinary Acidification in Recurrent Stone Formers.

Dhayat NA, Schaller A, Albano G, Poindexter J, Griffith C, Pasch A, Gallati S, Vogt B, Moe OW, Fuster DG.

J Am Soc Nephrol. 2016 May;27(5):1544-54. doi: 10.1681/ASN.2015040367. Epub 2015 Oct 9.

37.

Serum Calcification Propensity Is a Strong and Independent Determinant of Cardiac and All-Cause Mortality in Kidney Transplant Recipients.

Dahle DO, Åsberg A, Hartmann A, Holdaas H, Bachtler M, Jenssen TG, Dionisi M, Pasch A.

Am J Transplant. 2016 Jan;16(1):204-12. doi: 10.1111/ajt.13443. Epub 2015 Sep 16.

38.

Sodium thiosulfate ameliorates oxidative stress and preserves renal function in hyperoxaluric rats.

Bijarnia RK, Bachtler M, Chandak PG, van Goor H, Pasch A.

PLoS One. 2015 Apr 30;10(4):e0124881. doi: 10.1371/journal.pone.0124881. eCollection 2015.

39.

Calcification Propensity and Survival among Renal Transplant Recipients.

Keyzer CA, de Borst MH, van den Berg E, Jahnen-Dechent W, Arampatzis S, Farese S, Bergmann IP, Floege J, Navis G, Bakker SJ, van Goor H, Eisenberger U, Pasch A.

J Am Soc Nephrol. 2016 Jan;27(1):239-48. doi: 10.1681/ASN.2014070670. Epub 2015 Apr 29.

40.

Living kidney donation does not adversely affect serum calcification propensity and markers of vascular stiffness.

de Seigneux S, Ponte B, Berchtold L, Hadaya K, Martin PY, Pasch A.

Transpl Int. 2015 Sep;28(9):1074-80. doi: 10.1111/tri.12595. Epub 2015 May 18.

41.

Das Nephrotische Syndrom: Wann ist eine genetische Abklärung indiziert?

Pasch A.

Ther Umsch. 2015 Mar;72(3):195-7. doi: 10.1024/0040-5930/a000664. Review. German.

PMID:
25722313
42.

Sodium thiosulfate attenuates angiotensin II-induced hypertension, proteinuria and renal damage.

Snijder PM, Frenay AR, Koning AM, Bachtler M, Pasch A, Kwakernaak AJ, van den Berg E, Bos EM, Hillebrands JL, Navis G, Leuvenink HG, van Goor H.

Nitric Oxide. 2014 Nov 15;42:87-98. doi: 10.1016/j.niox.2014.10.002. Epub 2014 Oct 16.

PMID:
25459997
43.

Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats.

Snijder PM, Frenay AR, de Boer RA, Pasch A, Hillebrands JL, Leuvenink HG, van Goor H.

Br J Pharmacol. 2015 Mar;172(6):1494-504. doi: 10.1111/bph.12825.

44.

Impact of proton pump inhibitor use on magnesium homoeostasis: a cross-sectional study in a tertiary emergency department.

Lindner G, Funk GC, Leichtle AB, Fiedler GM, Schwarz C, Eleftheriadis T, Pasch A, Mohaupt MG, Exadaktylos AK, Arampatzis S.

Int J Clin Pract. 2014 Nov;68(11):1352-7. doi: 10.1111/ijcp.12469. Epub 2014 Jun 4.

PMID:
24898571
45.

Urinary sulfur metabolites associate with a favorable cardiovascular risk profile and survival benefit in renal transplant recipients.

van den Berg E, Pasch A, Westendorp WH, Navis G, Brink EJ, Gans RO, van Goor H, Bakker SJ.

J Am Soc Nephrol. 2014 Jun;25(6):1303-12. doi: 10.1681/ASN.2013050497. Epub 2014 Feb 7.

46.

The case | hypercalcemia in a 60-year-old male.

Helmuth A, Konrad M, Schlingmann KP, Pasch A.

Kidney Int. 2014 Jan;85(1):219-21. doi: 10.1038/ki.2013.184. No abstract available.

47.

Serum calcification propensity predicts all-cause mortality in predialysis CKD.

Smith ER, Ford ML, Tomlinson LA, Bodenham E, McMahon LP, Farese S, Rajkumar C, Holt SG, Pasch A.

J Am Soc Nephrol. 2014 Feb;25(2):339-48. doi: 10.1681/ASN.2013060635. Epub 2013 Oct 31.

48.

Primary male osteoporosis is associated with enhanced glucocorticoid availability.

Arampatzis S, Pasch A, Lippuner K, Mohaupt M.

Rheumatology (Oxford). 2013 Nov;52(11):1983-91. doi: 10.1093/rheumatology/ket228. Epub 2013 Jul 23.

49.

Improving the accuracy of daily satellite-derived ground-level fine aerosol concentration estimates for North America.

van Donkelaar A, Martin RV, Pasch AN, Szykman JJ, Zhang L, Wang YX, Chen D.

Environ Sci Technol. 2012 Nov 6;46(21):11971-8. doi: 10.1021/es3025319. Epub 2012 Oct 18.

PMID:
23013040
50.

Nanoparticle-based test measures overall propensity for calcification in serum.

Pasch A, Farese S, Gräber S, Wald J, Richtering W, Floege J, Jahnen-Dechent W.

J Am Soc Nephrol. 2012 Oct;23(10):1744-52. Epub 2012 Sep 6.

Supplemental Content

Support Center